98651-70-8 Usage
General Description
2-Amino-4-methoxypyridine-3-carbonitrile is a chemical compound with the molecular formula C7H8N4O. It is a pyridine derivative with a carbonitrile functional group and a methoxy and amino substituent. 2-amino-4-methoxypyridine-3-carbonitrile is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It has been reported to have potential biological activities, such as antimicrobial and anticancer properties. Additionally, 2-amino-4-methoxypyridine-3-carbonitrile is a yellow to brown solid substance with a melting point of approximately 112-114°C. Overall, this chemical is important in the field of medicinal and agricultural chemistry due to its versatile reactivity and potential biological activity.
Check Digit Verification of cas no
The CAS Registry Mumber 98651-70-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,6,5 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 98651-70:
(7*9)+(6*8)+(5*6)+(4*5)+(3*1)+(2*7)+(1*0)=178
178 % 10 = 8
So 98651-70-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H7N3O/c1-11-6-2-3-10-7(9)5(6)4-8/h2-3H,1H3,(H2,9,10)
98651-70-8Relevant articles and documents
INDOLE AND BENZOXAZINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
-
Page/Page column 29, (2010/06/17)
The present invention relates to novel indole and benzoxazine derivatives which are positive allosteric modulators of the metabotropic glutamate receptor subtype 2 ("mGluR2") and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds for the prevention or treatment of neurological and psychiatric disorders and diseases in which mGluR2 is involved.
SULFONAMIDES
-
, (2008/06/13)
The invention relates to compounds of formula (I) in which R6, R7, R8, R9 and X have the meanings cited in Claim 1. These compounds are inhibitors of tyrosinkinases, particularly TIE-2, and Raf kinases and can, among other things, be used for treating tumors.